FAILURE OF TUBERCULOSIS CHEMOTHERAPY IN A HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENT

被引:18
作者
DYLEWSKI, J
THIBERT, L
机构
[1] ST MARYS HOSP,DIV MICROBIOL & INFECT DIS,MONTREAL,QUEBEC,CANADA
[2] QUEBEC PUBL HLTH LAB,MYCOBACTERIOL LAB,ST ANNE BELLEVUE,QUEBEC,CANADA
关键词
D O I
10.1093/infdis/162.3.778
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:778 / 779
页数:2
相关论文
共 8 条
  • [1] LEVYFREBAULT V, 1987, J CLIN MICROBIOL, V25, P154
  • [2] PABLOSMENDEZ A, 1989, 5TH INT C AIDS MONTR
  • [3] PITCHENIK AE, 1988, CLIN CHEST MED, V9, P425
  • [4] SNIDER DE, 1984, AM REV RESPIR DIS, V130, P1095
  • [5] TUBERCULOSIS AS A MANIFESTATION OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS)
    SUNDERAM, G
    MCDONALD, RJ
    MANIATIS, T
    OLESKE, J
    KAPILA, R
    REICHMAN, LB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (03): : 362 - 366
  • [6] FAILURE OF OPTIMAL 4-DRUG SHORT-COURSE TUBERCULOSIS CHEMOTHERAPY IN A COMPLIANT PATIENT WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    SUNDERAM, G
    MANGURA, BT
    LOMBARDO, JM
    REICHMAN, LB
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (06): : 1475 - 1478
  • [7] 1983, AM REV RESPIR DIS, V128, P336
  • [8] 1989, MMWR-MORBID MORTAL W, V38, P236